Dr. Spitz has a long standing interest in genetic susceptibility to lung cancer. She has developed a lung cancer risk prediction model, has participated in lung cancer GWAS and is a founding member of the International Lung Cancer Consortium. She has outlined an integrative approach to extend the boundaries of molecular cancer epidemiology by integrating modern and rapidly evolving "omics" technologies into state-of-the-art molecular epidemiology in order to comprehensively explore the mechanistic underpinnings of epidemiologic observations into cancer risk and outcome. Dr. Spitz has been a recipient of numerous honors, most recently the Association of American Cancer Institutes' Distinguished Scientist Award. She has served as co-chair of the National Cancer Institute's Lung Cancer Progress Review Group and was a member of its Board of Scientific Advisors. She also participates in the external scientific advisory committees of several major cancer centers and SPORES.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.